Objective To compare the frequency of Ureaplasma-positive gastric fluid
(GF) cultures based on the cause and mode of delivery in preterm
newborns. Design Retrospective cohort study. Setting A single university
hospital in South Korea. Population Women with a singleton pregnancy who
delivered prematurely (between 23+0 and 32+0 weeks of gestation, N=464).
Methods The newborns’ GF was obtained on the day of birth via
nasogastric intubation. The frequency of Ureaplasma-positive GF cultures
was compared according to the cause and mode of delivery. Main outcome
measures Ureaplasma spp.-positivity in GF cultures. Results Ureaplasma
spp. was detected in 20.3% of the GF samples. The presence of
Ureaplasma spp. was significantly higher in the spontaneous preterm
birth group than in the indicated preterm birth group (30.2% vs 3.0%;
P < 0.001). Additionally, Ureaplama spp. was more frequently
found in the vaginal delivery group than in the cesarean delivery group,
irrespective of the cause of preterm delivery [indicated preterm birth
group (22.2% vs. 1.9%, P = 0.023); spontaneous preterm birth group
(37.7% vs. 24.2%, P = 0.015)]. Conclusions Ureaplasma spp. were
found in 20.3% of the GFs. However, only 1.9% of newborns in the
indicated preterm birth group with cesarean delivery had a
Ureaplasma-positive GF culture. Our findings support the view that the
amniotic cavity is a sterile environment before the onset of
parturition. Funding Ministry of Health & Welfare and Ministry of
Science and ICT, Republic of Korea (Grant No. HI22C1859) and the Seoul
National University Bundang Hospital Research Fund (Grant No.
14-2021-0025).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.